PMAM
ZYME icon

Picton Mahoney Asset Management’s Zymeworks ZYME Stock Holding History

Picton Mahoney Asset Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.43M Buy
256,690
+11,892
+5% +$281K 0.05% 325
2025
Q4 		$6.45M Buy
244,798
+38,476
+19% +$839K 0.05% 282
2025
Q3 		$3.52M Sell
206,322
-1,280
-0.6% -$18.3K 0.03% 324
2025
Q2 		$2.6M Sell
207,602
-427
-0.2% -$5.09K 0.03% 309
2025
Q1 		$2.48M Buy
208,029
+1,460
+0.7% +$19.9K 0.04% 235
2024
Q4 		$3.02M Sell
206,569
-38,087
-16% -$533K 0.06% 211
2024
Q3 		$3.07M Sell
244,656
-102
-0% -$1.11K 0.1% 191
2024
Q2 		$2.08M Sell
244,758
-39,620
-14% -$353K 0.08% 214
2024
Q1 		$2.99M Sell
284,378
-72,528
-20% -$805K 0.09% 182
2023
Q4 		$3.71M Sell
356,906
-1,912
-0.5% -$15.2K 0.1% 154
2023
Q3 		$2.27M Buy
358,818
+8,654
+2% +$63.9K 0.07% 195
2023
Q2 		$3.02M Buy
350,164
+32,644
+10% +$292K 0.13% 188
2023
Q1 		$2.87M Buy
317,520
+58,516
+23% +$510K 0.13% 203
2022
Q4 		$2.04M Buy
259,004
+154,599
+148% +$1.09M 0.1% 275
2022
Q3 		$640K Sell
104,405
-14,109
-12% -$85K 0.02% 474
2022
Q2 		$628K Buy
118,514
+31,368
+36% +$190K 0.02% 572
2022
Q1 		$572K Sell
87,146
-12,639
-13% -$113K 0.02% 610
2021
Q4 		$1.64M Sell
99,785
-30,390
-23% -$634K 0.04% 461
2021
Q3 		$3.78M Buy
130,175
+66,950
+106% +$2.23M 0.14% 173
2021
Q2 		$2.19M Buy
+63,225
New +$2.01M 0.06% 292
2021
Q1 		– Sell
-65,583
Closed -$3.1M – 402
2020
Q4 		$3.1M Buy
65,583
+127
+0.2% +$5.9K 0.15% 177
2020
Q3 		$3.05M Sell
65,456
-50,981
-44% -$1.75M 0.17% 159
2020
Q2 		$4.2M Sell
116,437
-15,365
-12% -$566K 0.24% 113
2020
Q1 		$4.67M Sell
131,802
-3,884
-3% -$159K 0.26% 92
2019
Q4 		$6.17M Buy
+135,686
New +$4.93M 0.42% 78

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Picton Mahoney Asset Management's ZYME Position: Q1 2026 in Review

Picton Mahoney Asset Management increased its Zymeworks (ZYME) stake by 4.9% in Q1 2026, buying an estimated $281K and bringing the position to 256,690 shares worth $6.43M. The position accounts for 0.05% of the portfolio, ranked #325.

Picton Mahoney Asset Management first reported a position in ZYME in Q4 2019 and has held it in 25 quarters since. The position peaked at $6.45M in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Picton Mahoney Asset Management held 256,690 shares of Zymeworks worth $6.43M as of Q1 2026.
  • Picton Mahoney Asset Management bought 11,892 Zymeworks shares in Q1 2026, an estimated $281K.
  • Zymeworks made up 0.05% of Picton Mahoney Asset Management's portfolio in Q1 2026, its #325 holding.
  • Picton Mahoney Asset Management first reported a position in Zymeworks in Q4 2019 and has held it in 25 quarters since.
  • Picton Mahoney Asset Management's Zymeworks position peaked at $6.45M in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2026, filed 13 May 2026.